Skip to main content

SENSIENT TECHNOLOGIES CORP

For the period ended Jun 30, 2025. Filed Aug 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 5, 2025

SXT$121.68+2.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to Consolidated Condensed Financial Statements

1.Accounting Policies

In the opinion of Sensient Technologies Corporation (the Company), the accompanying unaudited consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) that are necessary to present fairly the financial position of the Company as of June 30, 2025, and the results of operations, comprehensive income, and shareholders’ equity for the three and six months ended June 30, 2025 and 2024, and cash flows for the six months ended June 30, 2025 and 2024. The results of operations for any interim period are not necessarily indicative of the results to be expected for the full year.

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. Expenses are charged to operations in the period incurred.

Recently Adopted Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires the Company to disclose segment expenses that are significantand regularly provided to the Company’s chief operating decision maker (CODM). In addition, this ASU requires the Company to disclose the title and position of its CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. The Company adopted this standard in the fourth quarter of 2024 using a retrospective transition method, and the adoption did not have a material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. This ASU will also require the Company to disaggregate its income taxes paid disclosure by federal, state, and foreign taxes, with further disaggregation required for significant individual jurisdictions. This ASU is effective for fiscal years beginning after December 15, 2024. The Company will adopt this ASU in the fourth quarter of 2025 using a prospective transition method. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and its related disclosures.

In November 2024, the FASB issued ASU No. 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40) – Disaggregation of Income Statement Expenses, which will require the Company to disclose disaggregated information about certain income statement expense line items. This ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements and its related disclosures.

Please refer to the notes in the Company’s annual consolidated financial statements for the year ended December 31, 2024, for additional details of the Company’s financial condition and a description of the Company’s accounting policies, which have been continued without change.

2.Acquisition

On February 14, 2025, the Company acquired Biolie SAS, a natural color extraction business located in France. The Company paid $4.9 million in cash for this acquisition, which is net of $0.2 million in debt assumed. The assets acquired and liabilities assumed were recorded at their estimated fair value as of the acquisition date. The Company acquired net assets of $0.3 million, with the remaining $4.6 million allocated to goodwill. This business is part of the Color segment.

Index

3.Portfolio Optimization Plan

During the fourth quarter of 2023, the Board of Directors of the Company approved a plan to undertake an effort to optimize certain production facilities and improve efficiencies within the Company (Portfolio Optimization Plan). As part of the Portfolio Optimization Plan, in the Flavors & Extracts segment, the Company evaluated the closure of its manufacturing facility in Felinfach, Wales, United Kingdom, the closure of its sales office in Granada, Spain, and the centralization and elimination of certain selling and administrative positions. In addition, in the Color segment, the Company evaluated the closure of a manufacturing facility in Delta, British Columbia, Canada, the closure of a sales office in Argentina, and centralizing and eliminating certain production positions and selling and administrative positions. The Company reports all costs associated with the Portfolio Optimization Plan in the Corporate & Other segment.

The Company’s Felinfach sitewas shut down in May 2025, andall production activities have been transferred to other locations. The Company began marketing the Felinfach site for sale in June 2025. As a result, the Company met all of the assets held for sale criteria for the Felinfach land and building assets, which have been recorded as the only balance in Fixed assets held for sale on the Consolidated Balance Sheets. The Company has substantially completed all other actions contemplated under the Portfolio Optimization Plan in accordance with local laws.

The Company recorded $0.3 million and $2.5 million of accrued liabilities in Other Accrued Expenses on the Company’s Consolidated Balance Sheets related to the Portfolio Optimization Plan as of June 30, 2025 and December 31, 2024, respectively. The Company expects the Portfolio Optimization Plan will cost approximately $45 million (increased from $40 million, as previously disclosed, primarily due to higher than anticipated decommissioning costs), of which $40.7 million has been incurred through June 30, 2025, primarily related to non-cash impairment charges and employee separation costs. We anticipate that the Portfolio Optimization Plan will reduce annual operating costs by approximately $8 million to $10 million, with the full benefit expected to be achieved after 2025. The Company reduced headcount by approximately 100 positions, primarily in the Flavors & Extracts and Color segments, related to certain production and selling and administrative positions.

The following table summarizes the Portfolio Optimization Plan expenses by segment for the three months ended June 30, 2025:

(In thousands) · Flavors & Extracts · Color · Corporate & Other · Consolidated
Non-cash impairment charges – Selling and administrative expenses$117$-$-$117
Non-cash charges – Cost of products sold326--326
Employee separation – Selling and administrative expenses234--234
Other production costs – Cost of products sold1,463--1,463
Other costs – Selling and administrative expenses(1)937971651,199
Total$3,077$97$165$3,339
(1)Other costs include professional services, decommissioning costs, and other related costs.

The following table summarizes the Portfolio Optimization Plan expenses by segment for the six months ended June 30, 2025:

(In thousands) · Flavors & Extracts · Color · Corporate & Other · Consolidated
Non-cash impairment charges – Selling and administrative expenses$117$-$-$117
Non-cash charges – Cost of products sold1,181--1,181
Employee separation – Selling and administrative expenses4808-488
Other production costs – Cost of products sold2,422--2,422
Other costs – Selling and administrative expenses(1)1,7281021651,995
Total$5,928$110$165$6,203
(1)Other costs include professional services, decommissioning costs, and other related costs.

Index

The following table summarizes the Portfolio Optimization Plan expenses by segment for the three months ended June 30, 2024:

(In thousands) · Flavors & Extracts · Color · Corporate & Other · Consolidated
Non-cash impairment charges – Selling and administrative expenses$-$154$-$154
Non-cash charges – Cost of products sold283(176)-107
Employee separation – Selling and administrative expenses24035-275
Other production costs – Cost of products sold100--100
Other costs – Selling and administrative expenses(1)743400(27)1,116
Total$1,366$413$(27)$1,752
(1)Other costs include professional services, decommissioning costs, accelerated depreciation, accelerated lease costs, and other related costs.

The following table summarizes the Portfolio Optimization Plan expenses by segment for the six months ended June 30, 2024:

(In thousands) · Flavors & Extracts · Color · Corporate & Other · Consolidated
Non-cash impairment charges – Selling and administrative expenses$-$1,129$-$1,129
Non-cash charges – Cost of products sold408(194)-214
Employee separation – Selling and administrative expenses851526281,405
Other production costs – Cost of products sold100--100
Other costs – Selling and administrative expenses(1)1,059684(27)1,716
Total$2,418$2,145$1$4,564
(1)Other costs include professional services, decommissioning costs, accelerated depreciation, accelerated lease costs, and other related costs.
4.Trade Accounts Receivable

Trade accounts receivables are recorded at their face amount, less an allowance for expected losses on doubtful accounts. The allowance for doubtful accounts is calculated based on customer-specific analysis and an aging methodology using historical loss information. The Company believes historical loss information is a reasonable basis for expected credit losses as the Company’s historical credit loss experience correlates with its customer delinquency status. This information is also adjusted for any known current economic conditions. Forecasted economic conditions have not had a significant impact on the current credit loss estimate due to the short-term nature of the Company’s customer receivables; however, the Company will continue to monitor and evaluate the rapidly changing economic conditions. Additionally, as the Company only hasone portfolio segment, there are not different risks between portfolios. Specific accounts are written off against the allowance for doubtful accounts when the receivable is deemed no longer collectible.

The following table summarizes the changes in the allowance for doubtful accounts during the three and six month periods ended June 30, 2025 and 2024:

(In thousands) Three Months Ended June 30, 2025Allowance for Doubtful Accounts
Balance at March 31, 2025$5,205
Provision for expected credit losses390
Accounts written off(174)
Translation and other activity191
Balance at June 30, 2025$5,612
(In thousands) Three Months Ended June 30, 2024Allowance for Doubtful Accounts
Balance at March 31, 2024$3,882
Provision for expected credit losses496
Accounts written off(5)
Translation and other activity(98)
Balance at June 30, 2024$4,275

Index

(In thousands) Six Months Ended June 30, 2025Allowance for Doubtful Accounts
Balance at December 31, 2024$5,023
Provision for expected credit losses744
Accounts written off(465)
Translation and other activity310
Balance at June 30, 2025$5,612
(In thousands) Six Months Ended June 30, 2024Allowance for Doubtful Accounts
Balance at December 31, 2023$4,373
Provision for expected credit losses803
Accounts written off(752)
Translation and other activity(149)
Balance at June 30, 2024$4,275
5.Inventories

At June 30, 2025, and December 31, 2024, inventories included finished and in-process products totaling $435.3 million and $426.8 million, respectively, and raw materials and supplies of $184.3 million and $173.5 million, respectively.

6.Debt

On June 13, 2025, the Company entered into a Fourth Amended and Restated Credit Agreement (Credit Agreement). The Credit Agreement provides for a $400 million senior unsecured revolving credit facility, with up to $20 million of the facility being available as a sub-facility for standby and commercial letters of credit and sub-limits of up to $50 million on swing line loans. The Credit Agreement amended and restated the Company’s Third Amended and Restated Credit Agreement to, among other things, (i) increase the aggregate revolving commitment amount from $350 million to $400 million, (ii) increase the incremental revolving commitment from $100 million to $150 million, (iii) extend the maturity of the Company’s revolving credit facility from May 2026 to June 2030, and (iv) modify certain other provisions. Funds are available in U.S. dollars, Euros, English pounds, and other major currencies. Proceeds from the facility will be used to refinance existing indebtedness of the Company, for working capital, and other general corporate purpose needs, including capital expenditures, of the Company.

On June 13, 2025, the Company also amended its term loan agreement with PNC Bank, N.A. to extend the termination date from November 2025 to June 2027.

On June 30, 2025, the Company entered into Amendment No. 12 (Receivables Amendment) to the Receivables Purchase Agreement, dated October 3, 2016. The Receivables Amendment amends the Receivables Purchase Agreement to, among other things, (i) increase the facility limit from $85 million to $105 million and (ii) extend the termination date of the Receivables Purchase Agreement from August 29, 2025 to August 31, 2026.

7.Fair Value

Accounting Standards Codification 820, Fair Value Measurement, defines fair value for financial assets and liabilities, establishes a framework for measuring fair value in GAAP, and expands disclosures about fair value measurements. The carrying values of the Company’s cash and cash equivalents, trade accounts receivable, trade accounts payable, accrued expenses, and short-term borrowings were approximately the same as the fair values as of June 30, 2025 and December 31, 2024. The net fair value of the forward exchange contracts based on current pricing obtained for comparable derivative products (Level 2 inputs) was an asset of $0.9 million and a liability of $0.8 million as of June 30, 2025 and December 31, 2024, respectively. The fair value of the Company’s long-term debt, includingthe portions of long-term debt classified as Short-term borrowings on the Company’s Consolidated Balance Sheets, is estimated using discounted cash flows based on the Company’s current incremental borrowing rates for similar types of borrowing arrangements (Level 2 inputs). The carrying value of the long-term debt at June 30, 2025 and December 31, 2024, was $735.3 million and $613.7 million, respectively. The fair value of the long-term debt at June 30, 2025 and December 31, 2024, was $745.9 million and $622.0 million, respectively.

Index

8.Segment Information

The Company evaluates performance based on operating income before share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders); restructuring and other charges, including Portfolio Optimization Plan costs; interest expense; and income taxes (segment operating income). Total revenue and segment operating income by business segment and geographic region include both sales to customers, as reported in the Company’s Consolidated Statements of Earnings, and intersegment sales, which are accounted for at prices that approximate market prices and are eliminated in consolidation.

Assets by business segment and geographic region are those assets used in the Company’s operations in each segment and geographic region. Segment assets reflect the allocation of goodwill to each segment. Corporate & Other assets consist primarily of accounts receivables from the securitization program, investments, deferred tax assets, and fixed assets.

The Company determines its operating segments based on information utilized by its chief operating decision maker (CODM) to allocate resources and assess performance. The Company’s CODM is the President and Chief Executive Officer. The CODM uses segment operating income or loss to allocate resources, which includes employees, financial, or capital resources, predominantly in the annual budget and forecasting process. The CODM considers budget-to-actual and year-over-year variances on a monthly basis for segment operating income or loss when allocating capital and personnel resources to the segments. Segment performance is evaluated based on operating income of the respective business units before share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders) and restructuring and other charges, including the Portfolio Optimization Plan costs, which are reported in Corporate & Other.

The Company’sthree reportable segments are the Flavors & Extracts and Color segments, which are both managed on a product line basis, and the Asia Pacific segment, which is managed on a geographic basis. The Company’s Flavors & Extracts segment produces flavor, extracts, and essential oils products that impart a desired taste, texture, aroma, or other characteristics to a broad range of consumer and other products. The Color segment produces natural and synthetic color systems for foods, beverages, pharmaceuticals, and nutraceuticals; colors, ingredients, and systems for personal care; and technical colors for industrial applications. The Asia Pacific segment is managed on a geographic basis and produces and distributes color, flavor, and essential oils products for the Asia Pacific countries. The Company’s corporate expenses, share-based compensation (except for share-based compensation expense associated with stock grants to certain business unit leaders), and restructuring and other charges, including Portfolio Optimization Plan costs, are included in the “Corporate & Other” category.

Operating results by segment for the periods presented are as follows:

(In thousands) · Flavors & Extracts · Color · Asia Pacific · Corporate & Other · Consolidated
Three months ended June 30, 2025:
Total segment revenue$203,251$179,282$42,744$-$425,277
Intersegment revenue(5,770)(5,210)(67)-(11,047)
Consolidated revenue from external customers197,481174,07242,677-414,230
Cost of products sold142,625101,76225,2221,789271,398
Selling and administrative expense26,35033,3888,51216,87685,126
Operating income (loss)28,50638,9228,943(18,665)57,706
Interest expense7,391
Earnings before income taxes$50,315
Assets843,445887,924130,214342,9782,204,561
Capital expenditures14,4724,9594291,32121,181
Depreciation and amortization7,6766,06257095215,260
Three months ended June 30, 2024:
Total segment revenue$209,213$167,700$38,580$-$415,493
Intersegment revenue(7,193)(4,775)--(11,968)
Consolidated revenue from external customers202,020162,92538,580-403,525
Cost of products sold149,346100,34922,901207272,803
Selling and administrative expense26,46531,0747,79915,72781,065
Operating income (loss)26,20931,5027,880(15,934)49,657
Interest expense7,653
Earnings before income taxes$42,004
Assets763,530831,381112,361287,5951,994,867
Capital expenditures4,9174,8428741,18711,820
Depreciation and amortization7,6385,7496171,01215,016

Index

(In thousands) · Flavors & Extracts · Color · Asia Pacific · Corporate & Other · Consolidated
Six months ended June 30, 2025:
Total segment revenue$396,932$347,032$84,645$-$828,609
Intersegment revenue(11,653)(10,324)(77)-(22,054)
Consolidated revenue from external customers385,279336,70884,568-806,555
Cost of products sold280,559198,19949,5853,603531,946
Selling and administrative expense51,22564,73516,59830,815163,373
Operating income (loss)53,49573,77418,385(34,418)111,236
Interest expense14,732
Earnings before income taxes$96,504
Assets843,445887,924130,214342,9782,204,561
Capital expenditures27,0088,4816041,94238,035
Depreciation and amortization15,31611,9981,1181,90230,334
Six months ended June 30, 2024:
Total segment revenue$402,305$327,725$78,886$-$808,916
Intersegment revenue(12,263)(8,436)(22)-(20,721)
Consolidated revenue from external customers390,042319,28978,864-788,195
Cost of products sold288,328195,35246,930314530,924
Selling and administrative expense51,82760,75615,27830,347158,208
Operating income (loss)49,88763,18116,656(30,661)99,063
Interest expense14,698
Earnings before income taxes$84,365
Assets763,530831,381112,361287,5951,994,867
Capital expenditures9,49810,0591,2642,02922,850
Depreciation and amortization15,25811,1891,2532,02529,725

Index

Product Lines

(In thousands) · Flavors & Extracts · Color · Asia Pacific · Consolidated
Three months ended June 30, 2025:
Flavors, Extracts & Flavor Ingredients$141,736$-$-$141,736
Natural Ingredients61,515--61,515
Food & Pharmaceutical Colors-136,377-136,377
Personal Care-42,905-42,905
Asia Pacific--42,74442,744
Intersegment Revenue(5,770)(5,210)(67)(11,047)
Total revenue from external customers$197,481$174,072$42,677$414,230
Three months ended June 30, 2024:
Flavors, Extracts & Flavor Ingredients$134,749$-$-$134,749
Natural Ingredients74,464--74,464
Food & Pharmaceutical Colors-125,327-125,327
Personal Care-42,373-42,373
Asia Pacific--38,58038,580
Intersegment Revenue(7,193)(4,775)-(11,968)
Total revenue from external customers$202,020$162,925$38,580$403,525
(In thousands) · Flavors & Extracts · Color · Asia Pacific · Consolidated
Six months ended June 30, 2025:
Flavors, Extracts & Flavor Ingredients$271,917$-$-$271,917
Natural Ingredients125,015--125,015
Food & Pharmaceutical Colors-260,977-260,977
Personal Care-86,055-86,055
Asia Pacific--84,64584,645
Intersegment Revenue(11,653)(10,324)(77)(22,054)
Total revenue from external customers$385,279$336,708$84,568$806,555
Six months ended June 30, 2024:
Flavors, Extracts & Flavor Ingredients$259,554$-$-$259,554
Natural Ingredients142,751--142,751
Food & Pharmaceutical Colors-242,385-242,385
Personal Care-85,340-85,340
Asia Pacific--78,88678,886
Intersegment Revenue(12,263)(8,436)(22)(20,721)
Total revenue from external customers$390,042$319,289$78,864$788,195

Geographic Markets

(In thousands)Flavors & ExtractsColorAsia PacificConsolidated
Three months ended June 30, 2025:
North America$152,292$84,402$14$236,708
Europe33,28450,6861683,986
Asia Pacific4,72217,04841,07862,848
Other7,18321,9361,56930,688
Total revenue from external customers$197,481$174,072$42,677$414,230
Three months ended June 30, 2024:
North America$156,650$82,535$82$239,267
Europe32,06445,8256077,949
Asia Pacific5,10315,64837,01757,768
Other8,20318,9171,42128,541
Total revenue from external customers$202,020$162,925$38,580$403,525

Index

(In thousands)Flavors & ExtractsColorAsia PacificConsolidated
Six months ended June 30, 2025:
North America$301,919$163,071$15$465,005
Europe61,44198,40938159,888
Asia Pacific9,24433,67481,842124,760
Other12,67541,5542,67356,902
Total revenue from external customers$385,279$336,708$84,568$806,555
Six months ended June 30, 2024:
North America$303,602$157,655$82$461,339
Europe64,22191,987106156,314
Asia Pacific8,80933,06775,702117,578
Other13,41036,5802,97452,964
Total revenue from external customers$390,042$319,289$78,864$788,195
9.Retirement Plans

The Company’s components of annual benefit cost for the defined benefit plans for the periods presented are as follows:

Three Months Ended June 30,Six Months Ended June 30,
(In thousands)2025202420252024
Service cost$376$509$745$881
Interest cost455529899930
Expected return on plan assets(276)(260)(541)(502)
Recognized actuarial gain(71)(91)(143)(182)
Total defined benefit expense$484$687$960$1,127

The Company’s non-service cost portion of defined benefit expense is recorded in Interest Expenseon the Company’s Consolidated Statements of Earnings. The Company’s service cost portion of defined benefit expense is recorded in Selling and Administrative Expenses on the Company’s Consolidated Statements of Earnings.

10.Derivative Instruments and Hedging Activity

The Company may use forward exchange contracts and foreign currency denominated debt to manage its exposure to foreign exchange risk in order to reduce the effect of fluctuating foreign currencies on short-term foreign currency denominated intercompany transactions, non-functional currency raw material purchases, non-functional currency sales, and other known foreign currency exposures. These forward exchange contracts generally have maturities of less than 18 months. The Company’s primary hedging activities and their accounting treatment are summarized below.

Forward exchange contracts – Certain forward exchange contracts have been designated as cash flow hedges. The Company had $39.6 million and $70.3 millionof forward exchange contracts designated as cash flow hedges outstanding as of June 30, 2025 and December 31, 2024, respectively. For the three and six months ended June 30, 2025 and 2024, the amounts reclassified into net earnings in the Company’s Consolidated Statements of Earnings that offset the underlying transactions’ impact on earnings in the same period were not material. In addition, the Company utilizes forward exchange contracts that are not designated as cash flow hedges. The results of these transactions were not material to the financial statements of the Company.

Net investment hedges – The Company has designated certain foreign currency denominated long-term borrowings as partial hedges of the Company’s foreign currency net asset positions. As of June 30, 2025 and December 31, 2024, the total value of the Company’s net investment hedges was $334.9 million and $295.3 million, respectively. These net investment hedges included Euro and British Pound denominated long-term debt. Changes in the fair value of this debt attributable to changes in the spot foreign exchange rate are recorded in foreign currency translation in Other Comprehensive Income (OCI). For the three months ended June 30, 2025 and 2024, the impact of foreign exchange rates on these debt instruments increased debt by $26.8 million and decreased debt by $1.9 million, respectively, which has been recorded as foreign currency translation in OCI. For the six months ended June 30, 2025 and 2024, the impact of foreign exchange rates on these debt instruments increased debt by $39.6 million and decreased debt by $8.5 million, respectively, which has been recorded as foreign currency translation in OCI.

11.Income Taxes

The effective income tax rates for the three months ended June 30, 2025 and 2024, were 25.3% and 26.4%, respectively. For the six months ended June 30, 2025 and 2024, the effective income tax rates were 25.3% and 26.7%, respectively. The effective tax rates for the three and six months ended June 30, 2025 and 2024 were both impacted by the mix of foreign earnings and changes in estimates associated with the finalization of prior year foreign tax items. The effective tax rates for both the three and six months ended June 30, 2024 were further impacted by the limited tax deductibility of costs related to the Portfolio Optimization Plan.

Index

12.Accumulated Other Comprehensive Income

The following table summarizes the changes in OCI during the three and six month periods ended June 30, 2025 and 2024:

(In thousands)Cash Flow Hedges (1)Pension Items (1)Foreign Currency ItemsTotal
Balances at December 31, 2024$(310)$(2,348)$(224,181)$(226,839)
Other comprehensive income before reclassifications1,724-52,43454,158
Amounts reclassified from OCI(691)(107)-(798)
Balances at June 30, 2025$723$(2,455)$(171,747)$(173,479)
(In thousands)Cash Flow Hedges (1)Pension Items (1)Foreign Currency ItemsTotal
Balances at March 31, 2025$509$(2,402)$(209,981)$(211,874)
Other comprehensive income before reclassifications716-38,23438,950
Amounts reclassified from OCI(502)(53)-(555)
Balances at June 30, 2025$723$(2,455)$(171,747)$(173,479)
(In thousands)Cash Flow Hedges (1)Pension Items (1)Foreign Currency ItemsTotal
Balances at December 31, 2023$997$(2,079)$(171,035)$(172,117)
Other comprehensive loss before reclassifications(537)-(25,163)(25,700)
Amounts reclassified from OCI(224)(136)-(360)
Balances at June 30, 2024$236$(2,215)$(196,198)$(198,177)
(In thousands)Cash Flow Hedges (1)Pension Items (1)Foreign Currency ItemsTotal
Balances at March 31, 2024$1,477$(2,147)$(175,058)$(175,728)
Other comprehensive loss before reclassifications(1,239)-(21,140)(22,379)
Amounts reclassified from OCI(2)(68)-(70)
Balances at June 30, 2024$236$(2,215)$(196,198)$(198,177)
(1)Cash Flow Hedges and Pension Items are net of tax.
13.Commitments and Contingencies

The Company is subject to various claims and litigation arising in the normal course of business. The Company establishes reserves for claims and proceedings when it is probable that liabilities exist, and reasonable estimates of loss can be made. While it is not possible to predict the outcome of these matters, based on our assessment of the facts and circumstances now known, we do not believe that these matters, individually or in the aggregate, will have a material adverse effect on our financial position. However, actual outcomes may be different from those expected and could have a material effect on our results of operations or cash flows in a particular period.

14.Subsequent Event

On July 24, 2025, the Company announced its quarterly dividend of $0.41 per share would be payable on September 2, 2025.

Index

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.